What would you like me to do with the uploaded PDF? For example: summarize it, extract key points, answer questions, translate it, or convert its contents into notes.
Diagnosis
Reading File
Reading File
Reading File
Browsing Directory
~/
Reading File
Searching the Web
clinical diagnosis differential diagnosis approach patient records imaging findings
Running Command
python -c "from pypdf import PdfReader; p='/tmp/workspace/attachments/fe514bea-e666-40f6-9db4-60dffe72d710/73cdfe4d-1d20-40c0-a969-a834f5812632.pdf'; r=PdfReader(p); print('PAGES',len(r.pages)); [print('---PAGE',i+1,'---\n', (pg.extract_text() or '')[:10000]) for i,pg in enumerate(r.pages)]"
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
microcytosis thalassemia
Searching PubMed
familial hypercholesterolemia diagnosis
Searching PubMed
hyperhomocysteinemia folate
No single diagnosis can be made from this blood report alone, but it shows several important, likely separate findings:
-
Mixed dyslipidemia, persistent and clinically significant
- Total cholesterol: 255 mg/dL
- LDL-C: 177 mg/dL - high
- Triglycerides: 214 mg/dL - high
- HDL-C: 36 mg/dL - low
- Non-HDL-C: 219 mg/dL - high
- Similar abnormalities have persisted across multiple tests since 2023.
At age 23, this pattern warrants a clinician review for primary or familial dyslipidemia, including familial combined hyperlipidemia. Classic heterozygous familial hypercholesterolemia is more typically associated with untreated LDL-C above 190 mg/dL, but your persistently high LDL at a young age still makes family history and further assessment important. Ask whether early cardiovascular disease, strokes, or very high cholesterol occur in parents, siblings, grandparents, aunts, or uncles. -
Microcytosis without anemia, suggestive of thalassemia trait
- RBC: 6.00 million/µL - high
- MCV: 75.2 femtolitres - low
- MCH: 25.5 pg - low
- Hemoglobin: 15.3 g/dL - normal
- Ferritin: 49.4 ng/mL, iron saturation 34% - normal iron stores
This combination, especially the high RBC count with low MCV and normal iron studies, is more consistent with a thalassemia carrier state/trait than iron-deficiency anemia. This is usually not dangerous, but it should be confirmed because it matters for family planning. The next test is hemoglobin electrophoresis or HPLC with HbA2 measurement. If that is normal but suspicion remains, an alpha-thalassemia evaluation may be considered. -
Folate deficiency with borderline-low vitamin B12, likely causing high homocysteine
- Folate/B9: 4.14 ng/mL - below the lab’s normal threshold
- Vitamin B12: 223 pg/mL - low-normal/borderline
- Homocysteine: 20.82 µmol/L - elevated
The likely working diagnosis is folate deficiency with possible functional B12 deficiency. Both can raise homocysteine. A low B12 level should not be missed, because taking folic acid alone can correct blood abnormalities while allowing B12-related nerve injury to progress.Discuss:- Serum methylmalonic acid (MMA), which helps identify true B12 deficiency
- Diet, alcohol intake, acid-suppressing medication, metformin, chronic diarrhea, celiac disease, and malabsorption
- Clinician-guided folate plus B12 treatment, rather than self-treating folate alone
-
Mild ALT elevation
- ALT/SGPT: 57 U/L - mildly raised
- AST, bilirubin, alkaline phosphatase, GGT, albumin: normal
This is a mild isolated liver-enzyme elevation. Given the high triglycerides and cholesterol, metabolic dysfunction-associated steatotic liver disease, formerly called fatty liver, is one possible cause. Alcohol, supplements, gym products, medications, viral hepatitis, and recent strenuous exercise can also contribute.Usual next steps: repeat liver enzymes after avoiding alcohol and non-essential supplements, review medicines, and consider an abdominal ultrasound and hepatitis B/C testing if it persists.
What is reassuring
- No diabetes: fasting glucose 82, HbA1c 5.5%
- Kidney function and urine albumin are normal
- Thyroid profile is normal
- Vitamin D is sufficient
- No anemia, infection pattern, or major inflammatory marker elevation
- Lipoprotein(a) is normal
- Urine routine is normal
Minor findings
- ESR 12 mm/hour is only minimally elevated and nonspecific.
- hs-CRP 2.87 mg/L is within the lab range but near the upper end. It should not be used for cardiac-risk assessment during recent infection, inflammation, injury, or strenuous exercise.
Priority follow-up
Book a consultation with a physician or lipid specialist within the next few weeks, taking this report and prior reports. Discuss:
- Repeat fasting lipid profile and blood-pressure, waist/BMI assessment
- Family history and assessment for inherited dyslipidemia
- Hb electrophoresis/HPLC with HbA2 for suspected thalassemia trait
- MMA, repeat B12 and folate, and evaluation for the cause of deficiency
- Repeat liver function test and consider liver ultrasound if ALT remains high
The persistent dyslipidemia and raised homocysteine are the main cardiovascular-risk issues to address early. Recent evidence also supports treating elevated homocysteine in the context of identifying and correcting folate/B12-related causes, although supplements are not a substitute for managing the cholesterol problem. A recent systematic review on hyperhomocysteinemia and a review of folic acid in hyperhomocysteinemia are consistent with this approach.
Create a one-page summary to share with my doctor
Reading File
Searching the Web
ACC AHA guideline severe primary hypercholesterolemia LDL 190 mg/dL familial hypercholesterolemia young adults
Searching PubMed
familial hypercholesterolemia diagnosis
Finding Sources
Clinical Summary for Doctor Review
Patient: Manav Kakar
Age/Sex: 23-year-old male
Report date: 17 July 2026
Purpose: Review persistent lipid abnormalities, microcytosis, elevated homocysteine, and mild ALT elevation.
Age/Sex: 23-year-old male
Report date: 17 July 2026
Purpose: Review persistent lipid abnormalities, microcytosis, elevated homocysteine, and mild ALT elevation.
Key abnormalities
1. Persistent mixed dyslipidemia
| Test | Current | Prior trend |
|---|---|---|
| Total cholesterol | 255 mg/dL | 261, 262, 239 |
| LDL-C | 177 mg/dL | 189, 186.6, 163.3 |
| Triglycerides | 214 mg/dL | 169, 177, 191 |
| HDL-C | 36 mg/dL | 38, 40, 37.5 |
| Non-HDL-C | 219 mg/dL | 223, 222, 201.5 |
| ApoB/ApoA1 ratio | 1.24 | elevated-risk range per lab |
Clinical question: Evaluate for primary/inherited dyslipidemia, including familial combined hyperlipidemia or familial hypercholesterolemia phenotype. Please review family history of premature ASCVD and lipid disorders. LDL-C is persistently high in a young adult, although below the usual untreated LDL-C threshold of 190 mg/dL associated with classic heterozygous familial hypercholesterolemia. Current ACC guidance supports early consideration of pharmacotherapy in young adults with LDL-C ≥160 mg/dL or a strong family history of premature ASCVD, alongside lifestyle treatment.
2. Microcytosis without anemia
| Test | Current |
|---|---|
| Hemoglobin | 15.3 g/dL |
| RBC count | 6.00 million/µL |
| MCV | 75.2 fL |
| MCH | 25.5 pg |
| RDW-CV | 15.5% |
| Ferritin | 49.4 ng/mL |
| Iron saturation | 34.4% |
Clinical question: Pattern of high RBC count with persistent low MCV/MCH and normal iron stores suggests possible thalassemia trait/carrier state, rather than iron deficiency. Consider peripheral smear and hemoglobin electrophoresis/HPLC with HbA2 quantification. Consider alpha-thalassemia assessment if electrophoresis is nondiagnostic and suspicion remains.
3. Folate deficiency, borderline B12, hyperhomocysteinemia
| Test | Current |
|---|---|
| Folate (B9) | 4.14 ng/mL - low |
| Vitamin B12 | 223 pg/mL - borderline-low |
| Homocysteine | 20.82 µmol/L - elevated |
Clinical question: Evaluate folate deficiency and possible functional B12 deficiency as contributors to raised homocysteine. Consider methylmalonic acid, repeat B12/folate, dietary review, medication/alcohol history, and malabsorption evaluation as appropriate. Please advise on B12 replacement before or together with folate treatment.
4. Mild isolated ALT elevation
| Test | Current |
|---|---|
| ALT/SGPT | 57 U/L |
| AST/SGOT | 28 U/L |
| Bilirubin, ALP, GGT, albumin | Normal |
Clinical question: Assess for metabolic dysfunction-associated steatotic liver disease in view of dyslipidemia. Please review alcohol intake, supplements, gym/weight-loss products, medications, recent intense exercise, and consider repeat LFTs, hepatitis screening, and liver ultrasound if persistent.
Other relevant results
- Fasting glucose 82 mg/dL, HbA1c 5.5%: no diabetes.
- Creatinine 0.95 mg/dL, eGFR 115 mL/min/1.73 m², urine ACR 2.11 mg/g: normal renal markers.
- TSH 3.302 with normal free T3/T4: euthyroid.
- Vitamin D 46.7 ng/mL: sufficient.
- Lipoprotein(a) 20.05 mg/dL: normal.
- hs-CRP 2.87 mg/L and ESR 12 mm/hr: borderline/nonspecific, interpret in clinical context.
Requested discussion / possible next steps
- Cardiovascular risk assessment, blood pressure, BMI/waist circumference, lifestyle review, and lipid-lowering management plan.
- Detailed family history and consideration of cascade lipid screening.
- Hb electrophoresis/HPLC with HbA2, with additional alpha-thalassemia testing if indicated.
- Methylmalonic acid and a plan for B12 plus folate correction.
- Repeat fasting lipid panel and liver enzymes after the management plan is initiated.
This is a shared conversation. Sign in to Orris to start your own chat.